Contiguous gene deletion syndrome, characterized by both TSC and polycystic kidney disease, affects up to 5% of TSC patients [2] and has been diagnosed in the two patients with TSC2 segmental deletions encompassing PKD1 exon 46, assisted in a multispecialty clinic. The gene discussed is TSC2; the disease is Down syndrome.